Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England

Osborne, V; Davies, M; Evans, A; Shakir, SAW

Osborne, V (corresponding author), Drug Safety Res Unit, Bursledon Hall,Blundell Lane, Southampton SO31 1AA, Hants, England.; Osborne, V (corresponding author), Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth, Hants, England.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2020; 10 ():

Abstract

Background: This study was designed to monitor the short-term (up to 12 weeks) use and safety of quetiapine (Seroquel) extended release (XL) and queti......

Full Text Link